GLP-1 Pricelist
This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.
August 18, 2026 · Price comparison authority

The Post-Wegovy-Pill Compounded Price Shift: What Actually Moved

The Wegovy pill's launch was expected to compress compounded pricing across the board. The actual six-month picture is more segmented — some categories moved sharply, others barely at all. Here's what actually happened.

What Moved

Compounded oral semaglutide pricing moved down. Programs that had positioned $199-$249 oral semaglutide as a premium alternative to injectable had to reprice against the brand-name pill's $149-$299 tier structure. Many now sit in a $99-$179 range or have shifted their oral marketing toward tirzepatide instead.

Compounded oral tirzepatide pricing didn't move — no brand-name oral tirzepatide exists to compete with, so the segment retained its $167-$229 tier.

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder — compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

What Didn't Move

Compounded injectable semaglutide pricing was largely unaffected. The Wegovy pill isn't a direct substitute for injection — patients who prefer or need injection paths continue to have distinct clinical and lifestyle reasons for that preference. Compounded injectable pricing has stayed in the $149-$299 range it settled into earlier in 2026.

Compounded injectable tirzepatide pricing was similarly unaffected. LillyDirect Zepbound remains injectable, so the competitive dynamic didn't shift materially.

Embody

Injectable semaglutide (verify current tier)

Lead compounded-injectable option with a $400 CPA tier.

  • Injectable semaglutide only
  • Standard titration schedule
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Telos Rx

Weight-loss LP1 tirzepatide

Compounded tirzepatide via direct pharmacy program.

  • Compounded tirzepatide focus
  • Direct-link intake format
  • Verify current pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Premium Programs Held

Programs positioning above $299/month on compounded — the premium and bundled service tiers — largely held their pricing. Their value proposition isn't purely on raw medication cost; it includes care team access, coaching, and bundled services that brand-name pathways don't include. Patients who value that bundle continue to pay for it.

Liv Body

$500 CPA tier

Higher-CPA compounded GLP-1 program.

  • Compounded GLP-1 fulfillment
  • Higher-priced tier
  • Verify current pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Oak Weight Loss

GLP-1 program

Telehealth program with compounded GLP-1 access.

  • Compounded semaglutide/tirzepatide
  • Standard telehealth intake
  • Membership-style pricing
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Warning-Letter Programs

Programs with active FDA warning letters have shown mixed pricing responses. Some cut pricing to maintain patient acquisition during regulatory uncertainty; others held pricing but tightened refund and cancellation terms. Patients considering these programs should weigh pricing against regulatory exposure directly.

⚠ MEDVi received an FDA Warning Letter. Verify current compliance before ordering.

MEDVi

$228 CPA tier

Included with warning banner. Read the note above.

  • Compounded GLP-1 program
  • Warning letter active
  • Independently verify status
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing
⚠ Sprout Health received FDA Warning Letter #715879. Verify current compliance before ordering.

Sprout Health

$250 CPA tier

Included with warning banner. Read the note above.

  • Compounded GLP-1 program
  • Warning letter #715879
  • Independently verify status
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

The Segmented Reality

The Wegovy pill's launch didn't compress the entire compounded market — it compressed the specific segment that competed most directly with an oral brand product. Everywhere else, the pre-launch pricing dynamics have held. Understanding your specific product-and-format decision helps you predict where price movements will affect your cost and where they won't.

SHED

Starts lower, $399/mo at 7.5mg+

Note: SHED's price jumps to $399/mo at 7.5mg or higher.

  • Lower entry pricing
  • Price jump at 7.5mg+
  • Compounded semaglutide + tirzepatide
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Care Bare Rx

GLP-1 weight loss program

Telehealth prescribing with compounded fulfillment.

  • Compounded GLP-1 options
  • Weight-loss intake funnel
  • Verify pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Where to Start

Embody

Injectable semaglutide (verify current tier)

Lead compounded-injectable option with a $400 CPA tier.

  • Injectable semaglutide only
  • Standard titration schedule
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder — compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing
Medical & editorial disclaimer. This article is for informational purposes only and is not medical advice. GLP-1 medications require prescriber evaluation. Compounded GLP-1 medications are not FDA-approved. Talk to a licensed clinician before starting, stopping, or changing any prescription. Provider pricing, availability, and program terms change frequently — verify current details on each provider's site before making a decision. Some links are affiliate links, which means we may earn a commission if you sign up; this does not change our recommendations or the price you pay.